ARWR Quote, Trading Chart, Arrowhead Pharmaceuticals Inc.

$43.42 Last:

-0.44% Change Percent:

$43.61 Open:

$43.42 Previous Close:

$44.29 High:

$43.22 Low:

818,892 Volume:

09/29/2020 04:58:26 pm Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Stock Date	Open Price	Close Price	High	Low	Volume
2020-09-29	43.61	43.42	44.29	43.22	818,892
2020-09-25	43.98	44.915	45.1	43.65	847,384
2020-09-24	44.17	44.31	45.73	42.99	855,739
2020-09-23	43.51	44.64	45.8167	43.28	1,736,044
2020-09-22	42.25	43.8	44.1	41.6	1,419,762
2020-09-21	41.67	41.71	43.56	41.26	1,294,300
2020-09-18	46.4741	43.1	46.4894	41.76	4,037,606
2020-09-17	46.36	45.75	48.95	45.55	2,649,496
2020-09-16	40.05	47.43	53.12	40.05	23,984,190
2020-09-15	34.48	33.8	34.96	33.61	1,034,394
2020-09-14	33.86	34.04	34.68	33.22	1,363,497
2020-09-11	35.53	33.21	35.66	32.86	1,894,878
2020-09-10	36.3189	35.2	37.805	34.9	1,261,785
2020-09-09	35.77	36.14	36.71	35.21	806,078
2020-09-08	35.25	35.47	36.8	34.5495	1,062,126
2020-09-07	37.5	36.04	37.98	34.002	1,201,729
2020-09-04	37.5	36.04	37.98	34.002	1,201,725
2020-09-03	39.5	37.06	39.605	36.75	1,048,876
2020-09-02	39.01	39.83	40.063	37.6601	1,032,320
2020-09-01	41.88	39	42.74	38.89	1,482,724

Stock Information

Arrowhead Pharmaceuticals Inc. Company Name:

ARWR Stock Symbol:

NASDAQ Market:

Get ARWR Alerts

News, Short Squeeze, Breakout and More Instantly...

ARWR - Arrowhead ARO-AAT Phase 2 Interim Results in Patients with Alpha-1 Liver Disease Demonstrate Improvements in Key Parameters after Six Months of Treatment

- Up to 97% reduction in intra-hepatic Z-AAT polymer - Up to 95% reduction in intra-hepatic total Z-AAT burden - Up to 66% and 58% reduction in circulating ALT and GGT levels respectively - Up to 26% improvement in FibroScan values Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR)...
ARWR - Should You Buy Vir Biotechnology Stock on the Dip?

One of the biggest winners among coronavirus stocks in 2020 has been Vir Biotechnology (NASDAQ: VIR) . The company's shares have more than doubled in the span of one year, turning a $10,000 investment from last September into about $22,700 today. That substantially outperformed the ...
ARWR - Arrowhead Pharmaceuticals Appoints Oye Olukotun to Board of Directors

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that the board of directors appointed veteran pharmaceutical industry executive Oye Olukotun, M.D., MPH, as an independent director of the company, with a term beginning effective September 1, 2020. Douglass Given, M.D., Ph.D.,...